Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.

Freeman EW.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:27-34; discussion 42-3.

PMID:
12659404
[PubMed - indexed for MEDLINE]
2.

Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.

Mansour D.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:35-41; discussion 42-3. Review.

PMID:
12659405
[PubMed - indexed for MEDLINE]
3.

[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].

Cianci A, De Leo V.

Minerva Ginecol. 2007 Aug;59(4):415-25. Review. Italian.

PMID:
17923832
[PubMed - indexed for MEDLINE]
4.

Yasmin: the reason why.

Thorneycroft IH.

Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:13-8; discussion 42-3. Review.

PMID:
12659402
[PubMed - indexed for MEDLINE]
5.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD006586. doi: 10.1002/14651858.CD006586.pub4. Review.

PMID:
22336820
[PubMed - indexed for MEDLINE]
6.

Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.

Fenton C, Wellington K, Moen MD, Robinson DM.

Drugs. 2007;67(12):1749-65. Review.

PMID:
17683173
[PubMed - indexed for MEDLINE]
7.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein AA, Helmerhorst FM.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006586. doi: 10.1002/14651858.CD006586.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD006586.

PMID:
19370644
[PubMed - indexed for MEDLINE]
8.

Oral contraceptives containing drospirenone for premenstrual syndrome.

Lopez LM, Kaptein A, Helmerhorst FM.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006586. doi: 10.1002/14651858.CD006586.pub2. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD006586.

PMID:
18254106
[PubMed - indexed for MEDLINE]
9.

Added benefits of drospirenone for compliance.

Foidart JM.

Climacteric. 2005 Oct;8 Suppl 3:28-34. Review.

PMID:
16203653
[PubMed - indexed for MEDLINE]
10.

A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.

Rapkin A.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:39-53. Review.

PMID:
12892989
[PubMed - indexed for MEDLINE]
11.

Drospirenone/ethinyl estradiol.

Rapkin AJ, Sorger SN, Winer SA.

Drugs Today (Barc). 2008 Feb;44(2):133-45. doi: 10.1358/dot.2008.44.2.1191057. Review.

PMID:
18389090
[PubMed - indexed for MEDLINE]
12.

Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive.

Keam SJ, Wagstaff AJ.

Treat Endocrinol. 2003;2(1):49-70. Review.

PMID:
15871554
[PubMed - indexed for MEDLINE]
13.

An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.

Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L, Mirkin S, Constantine GD.

Contraception. 2012 May;85(5):437-45. doi: 10.1016/j.contraception.2011.09.010. Epub 2011 Dec 5. Review.

PMID:
22152588
[PubMed - indexed for MEDLINE]
14.

Drospirenone: a novel progestin.

Rapkin AJ, Winer SA.

Expert Opin Pharmacother. 2007 May;8(7):989-99. Review.

PMID:
17472544
[PubMed - indexed for MEDLINE]
15.

[Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen].

Bruni Bresciani V.

Minerva Ginecol. 2010 Jun;62(3):261-6. Review. Italian.

PMID:
20595950
[PubMed - indexed for MEDLINE]
16.

Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Steiner M.

J Psychiatry Neurosci. 2000 Nov;25(5):459-68. Review.

PMID:
11109297
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.

Frackiewicz EJ, Shiovitz TM.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):437-47. Review.

PMID:
11372908
[PubMed - indexed for MEDLINE]
18.

Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough.

Halbreich U.

CNS Spectr. 2008 Jul;13(7):566-72. Review.

PMID:
18622361
[PubMed - indexed for MEDLINE]
19.

Treatment of premenstrual disorders.

Kroll R, Rapkin AJ.

J Reprod Med. 2006 Apr;51(4 Suppl):359-70. Review.

PMID:
16734319
[PubMed - indexed for MEDLINE]
20.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk